A key unsolved question in the current coronavirus disease 2019 (COVID-19) pandemic is
the duration of acquired immunity. Insights from infections with the four seasonal human …

Objectives To describe the role of bacteria (including bacterial resistance), viruses (including
those recently described) and mixed bacterial–viral infections in adults presenting to …

Background Mycoplasma pneumoniae respiratory infections are transmitted by aerosol and
droplets in close contact. Aim We investigated global M. pneumoniae incidence after …

Mycoplasma pneumoniae (M. pneumoniae) belongs to the class Mollicutes and has been
recognized as a common cause of respiratory tract infections (RTIs), including community-…

Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it? Page 1 Correspondence
www.thelancet.com/microbe Vol 3 December 2022 e897 Mycoplasma pneumoniae …

Objectives Following two studies conducted in 2005 and 2011, a third prevalence survey of
multidrug-resistant microorganisms (MDRO) was organised in Belgian nursing homes (NHs) …

Objectives To evaluate a testing algorithm for the rapid identification of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that includes the use of PCR-based …

Polymerase chain reaction (PCR) with real-time detection using two adjacent fluorescent
probes in a Lightcycler instrument was applied for detection of the Mycoplasma pneumoniae …

Background Most cases of adult pertussis probably remain undiagnosed. Aim To explore
the prevalence, diagnosis, and disease course of acute pertussis infection in adult patients …

Background Mycoplasma pneumoniae is a leading cause of community-acquired pneumonia,
with large epidemics previously described to occur every 4 to 7 years. Aim To better …